Malaga Cove Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,022
| Closed | -$304K | – | 176 |
|
2025
Q1 | $304K | Buy |
2,022
+185
| +10% | +$27.8K | 0.13% | 151 |
|
2024
Q4 | $339K | Sell |
1,837
-64
| -3% | -$11.8K | 0.13% | 152 |
|
2024
Q3 | $374K | Sell |
1,901
-1,955
| -51% | -$385K | 0.15% | 144 |
|
2024
Q2 | $797K | Buy |
3,856
+591
| +18% | +$122K | 0.32% | 81 |
|
2024
Q1 | $885K | Sell |
3,265
-102
| -3% | -$27.6K | 0.36% | 75 |
|
2023
Q4 | $796K | Buy |
3,367
+615
| +22% | +$145K | 0.34% | 85 |
|
2023
Q3 | $539K | Sell |
2,752
-30
| -1% | -$5.88K | 0.25% | 106 |
|
2023
Q2 | $585K | Hold |
2,782
| – | – | 0.27% | 100 |
|
2023
Q1 | $561K | Buy |
2,782
+667
| +32% | +$135K | 0.28% | 101 |
|
2022
Q4 | $461K | Buy |
2,115
+385
| +22% | +$83.9K | 0.25% | 104 |
|
2022
Q3 | $340K | Buy |
+1,730
| New | +$340K | 0.19% | 118 |
|